Assembly Biosciences, Inc. (ASMB) financial statements and ratios from SEC XBRL: revenue $0.1B (TTM), net margin -8.5%, revenue growth 38.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $72.30M |
| Revenue (TTM) | $0.1B |
| Net Margin | -8.5% |
| Operating Margin (TTM) | -11.8% |
| Revenue Growth (YoY) | 38.9% |
| EPS Growth (YoY) | -85.0% |
| FCF Growth (YoY) | -7.6% |
| Price / Book | 2.29 |
| Price / Sales | 9.35 |
| FCF Yield | -9.9% |
| Altman Z-Score | 3.00 (safe) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
ASMB overview · ASMB earnings · ASMB KPIs · ASMB investor relations · ASMB ownership · ASMB peers · ASMB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.